open access

Vol 92, No 9 (2021)
Guidelines / Expert consensus
Published online: 2021-08-06
Get Citation

Updating the recommendations of the Working Group for the Preservation of Fertility in Oncological and Hematological Patients and Other Patients Treating Gonadier Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology regarding cryopreserves and autologous transplant

Robert Jach1, Robert Spaczynski2, Rafal Kurzawa3, Michal Radwan4, Jakub Rzepka5, Malgorzata Swornik1, Wojciech Pabian6
DOI: 10.5603/GP.a2021.0151
·
Pubmed: 34541656
·
Ginekol Pol 2021;92(9):668-672.
Affiliations
  1. Collegium Medicum, Jagiellonian University, Cracow, Poland
  2. University of Medical Sciences, Department of Infertility and Reproductive Endocrinology, Poznan, Poland
  3. Vitrolive, The Fertility Partnership, Szczecin, Poland
  4. "Gameta" Infertility Treatment Clinic, Lodz, Poland
  5. Maria Sklodowska-Curie National Research Institute of Oncology. Department of Gynecologic Oncology, Warsaw, Poland
  6. University Hospital, Department of Gynecological Endocrinology and Gynecology, Cracow, Poland

open access

Vol 92, No 9 (2021)
RECOMMENDATIONS
Published online: 2021-08-06

Abstract

Update of the recommendations of the Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated with Gonadotoxic Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology regarding cryopreservation and autologous ovarian tissue transplantation.
The Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated with Gonadotoxic Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology has developed current clinical guidelines and recommendations to improve the quality of healthcare provision in the area of reproductive health in patients undergoing therapy that may impair their reproductive potential.
The guidelines are based on current scientific evidence available at the time of writing this document. In the absence of scientific evidence on some aspects, a consensus was reached among GROF stakeholders.
The purpose of the guidelines is to assist healthcare professionals in making decisions in specific clinical situations regarding the selection of an appropriate and effective diagnostic and therapeutic process. The document provides practical guidelines for the management of cryopreservation and autologous ovarian tissue transplantation.

Abstract

Update of the recommendations of the Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated with Gonadotoxic Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology regarding cryopreservation and autologous ovarian tissue transplantation.
The Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated with Gonadotoxic Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology has developed current clinical guidelines and recommendations to improve the quality of healthcare provision in the area of reproductive health in patients undergoing therapy that may impair their reproductive potential.
The guidelines are based on current scientific evidence available at the time of writing this document. In the absence of scientific evidence on some aspects, a consensus was reached among GROF stakeholders.
The purpose of the guidelines is to assist healthcare professionals in making decisions in specific clinical situations regarding the selection of an appropriate and effective diagnostic and therapeutic process. The document provides practical guidelines for the management of cryopreservation and autologous ovarian tissue transplantation.

Get Citation
About this article
Title

Updating the recommendations of the Working Group for the Preservation of Fertility in Oncological and Hematological Patients and Other Patients Treating Gonadier Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology regarding cryopreserves and autologous transplant

Journal

Ginekologia Polska

Issue

Vol 92, No 9 (2021)

Article type

Guidelines / Expert consensus

Pages

668-672

Published online

2021-08-06

DOI

10.5603/GP.a2021.0151

Pubmed

34541656

Bibliographic record

Ginekol Pol 2021;92(9):668-672.

Authors

Robert Jach
Robert Spaczynski
Rafal Kurzawa
Michal Radwan
Jakub Rzepka
Malgorzata Swornik
Wojciech Pabian

References (24)
  1. Jach R, Pabian W, Spaczyński R, et al. Recommendations of the Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated With Gonadotoxic Therapies "ONCOFERTILITY" (GROF) of the Polish Society of Oncological Gynecology. J Adolesc Young Adult Oncol. 2017; 6(3): 388–395.
  2. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019; 112(6): 1022–1033.
  3. Anderson RA, Amant F, Braat D, et al. ESHRE Guideline Group on Female Fertility Preservation. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020; 2020(4): hoaa052.
  4. Shapira M, Dolmans MM, Silber S, et al. Evaluation of ovarian tissue transplantation: results from three clinical centers. Fertil Steril. 2020; 114(2): 388–397.
  5. Andersen CY, Bollerup AC, Kristensen SG. Defining quality assurance and quality control measures in connection with ovarian tissue cryopreservation and transplantation: a call to action. Hum Reprod. 2018; 33(7): 1201–1204.
  6. Anderson RA, Wallace WH. Fertility preservation in girls and young women. Clin Endocrinol (Oxf). 2011; 75(4): 409–419.
  7. Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017; 32(5): 1046–1054.
  8. Karavani G, Schachter-Safrai N, Chill HH, et al. Single-Incision Laparoscopic Surgery for Ovarian Tissue Cryopreservation. J Minim Invasive Gynecol. 2018; 25(3): 474–479.
  9. Lotz L, Maktabi A, Hoffmann I, et al. Ovarian tissue cryopreservation and retransplantation--what do patients think about it? Reprod Biomed Online. 2016; 32(4): 394–400.
  10. Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018; 35(4): 561–570.
  11. Diaz-Garcia C, Domingo J, Garcia-Velasco JA, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018; 109(3): 478–485.e2.
  12. Pretalli JB, Frontczak Franck S, Pazart L, et al. DATOR Group. Development of Ovarian Tissue Autograft to Restore Ovarian Function: Protocol for a French Multicenter Cohort Study. JMIR Res Protoc. 2019; 8(9): e12944.
  13. Dolmans MM, Taylor HS, Rodriguez-Wallberg KA, et al. Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons. Fertil Steril. 2020; 114(4): 725–738.
  14. Luan Yi, Edmonds ME, Woodruff TK, et al. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol. 2019; 240(2): 243–256.
  15. Stern CJ, Gook D, Hale LG, et al. Delivery of twins following heterotopic grafting of frozen-thawed ovarian tissue. Hum Reprod. 2014; 29(8): 1828.
  16. Paradisi R, Macciocca M, Vicenti R, et al. New insights in the selection and management of cancer patients applicants for ovarian tissue cryopreservation. Gynecol Endocrinol. 2016; 32(11): 881–885.
  17. Pacheco F, Oktay K. Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis. Reprod Sci. 2017; 24(8): 1111–1120.
  18. Beckmann MW, Dittrich R, Lotz L, et al. Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience. Arch Gynecol Obstet. 2017; 295(4): 1033–1039.
  19. Beckmann MW, Dittrich R, Lotz L, et al. Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue. Reprod Biomed Online. 2018; 36(2): 188–196.
  20. van der Kooi ALLF, Kelsey TW, van den Heuvel-Eibrink MM, et al. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis. Eur J Cancer. 2019; 111: 126–137.
  21. Imbert R, Moffa F, Tsepelidis S, et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod. 2014; 29(9): 1931–1940.
  22. Poirot C, Fortin A, Lacorte JM, et al. CAROLéLISA Cooperative Group. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation. Hum Reprod. 2019; 34(6): 1083–1094.
  23. Lambertini M, Goldrat O, Ferreira AR, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018; 29(1): 237–243.
  24. Lambertini M, Di Maio M, Poggio F, et al. Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients. Reprod Biomed Online. 2019; 38(5): 835–844.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl